SCHOTT TopLyo® Pharmaceutical lyophilized vial for fogging prevention
BUY ONLINE NOWPrevent fogging and improve residual emptying
Due to the low stability of biologics, more than 50% are lyophilized. However, lyophilization can cause fogging, which results in an increase in rejects, while vials are often overfilled to compensate for losses due to poor residual emptying after reconstitution. A solution to both issues is the unique SCHOTT TopLyo® vial, which combines hydrophobic behavior and the avoidance of free silicone to prevent fogging and improve residual emptying during lyophilization.
Improved lyophilization for injectable drugs
A unique combination of hydrophobic behavior and no free silicone
SCHOTT TopLyo® vial for lyophilization features a chemically uniform hydrophobic coating that leads to less fogging during the lyophilization process, as well as lower disruption of the lyo cake. This results in fewer cosmetic rejects and reduced production costs.
The application of the coating via PICVD (plasma impulse chemical vapor deposition) forms a covalent bond, avoiding free silicone. SCHOTT Pharma´s vials for lyophilization are therefore unique in combining hydrophobic behavior and the avoidance of free silicone to avoid fogging and improve residual emptying.
Increased lyo process efficiency and patient safety
-
Made using high quality Type I FIOLAX® Borosilicate Glass.
-
Formats range from 2-50 R.
-
Packaging options include bulk tray, as well as pre-washed and pre-sterilized adaptiQ® (tray, cup nest)*.
-
TopLine quality level with an additional, dedicated, statistical in-production release test
Ready-to-use vial for lyophilization
Small batches of personalized medications and high-value pharmaceuticals often present challenges for fill-and-finish operations. Not only do they require higher quality containers, but they also require more flexibility, with frequent switching between different medications to avoid costly waste.
SCHOTT TopLyo® pharmaceutical glass vials are available in a pre-washed and pre-sterilized ready-to-use (RTU) configuration and can be processed on a variety of new and existing fill-and-finish lines, keeping vials nested throughout the process (including freeze-drying).